Langerhans Cell Histiocytosis in the Skull : Comparison of MR Image and Other Images

다국어 초록 (Multilingual Abstract)

Purpose : To evaluate the characteristic MR imaging findings of Langerhans cell histiocytosis (LCH) in the skull and to compare them with those of plain radiography and computed tomography.
Materials and Methods : A total of 10 lesions in 9 patients (Age range; 5-42 years, Mean age; 18, all women) with Langerhans cell histiocytosis in the skull were included in our study. Nine lesions in nine patients were histologically confirmed by surgery or fine needle aspiration biopsy. All patients performed with MRI, and plain radiography and CT scan were done in 7 patients (8 lesions). Two experienced neuroradiologists reviewed the radiological examinations independently with attention to location, size, shape and nature of the lesions in the skull and compared the extent and extension of the lesions to adjacent structures.
Results : The lesions were distributed in all of the skulls without predilection site. On MRI, the masses were shown as well-enhancing soft tissue masses (10/10) mainly in diploic spaces (8/10) with extension to scalp (9/10) and dura mater (7/10). Dural enhancement (7/10) and thickening (4/10) were seen. The largest diameter of the soft tissue masses ranged 1.1 cm to 6.8 cm, shaped as round (5/10) or oval (5/10). On CT scans, the lesions were presented as soft tissue masses involving diploic space (6/8) and scalp extension (7/8) were also well visualized. Although bony erosion or destruction was more clearly seen on CT rather than those of MRI, enhancement of soft tissue masses and dura were not well visualized on CT. In contrast, all of the lesions in LCH were seen as punched out (4/8), beveled-edge appearance (4/8) osteolytic masses in plain radiography, but scalp and dural extension could not be seen.
Conclusion : Characteristic MR findings in patients with LCH are soft tissue mass in diploic space with extension to dura and scalp, and MRI would be better imaging modality than plain radiography or CT.

참고문헌 (Reference)

1 Mirra JM, "radiologic, and pathologic correlations. Vol 2" Lea & Febiger 1021-1060, 1989

2 Arceci RJ, "The histiocytoses: the fall of the Tower of Babel" 35 : 747-767, 1999

3 Huang F, "The histiocytoses of infancy" 23 : 319-331, 1999

4 Ladisch S, "The histiocytoses" Lippincott 491-504, 1989

5 Rawlings CE 3rd, "Solitary eosinophilic granuloma of the skull" 15 : 155-161, 1984

6 Al-Abbadi M, "Soft tissue Langerhans’ cell histiocytosis in an adult" 121 : 169-172, 1997

7 Wilner D, "Radiology of bone tumors and allied disorders" Saunders 1330-1435, 1982

8 David R, "Radiologic features of eosinophilic granuloma of bone" 153 : 1021-1026, 1989

9 Kilborn TN, "Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings" 58 (58): 269-278, 2003

10 Schmitz L, "Nosology and pathology of Langerhans cell histiocytosis" 12 : 221-246, 1998

11 Keyaki A, "Magnetic resonance imaging of calvarial eosinophilic granuloma with pericranial soft tissue reaction-case report" 40 : 110-111, 2000

12 Prayer D, "MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis" 25 : 880-891, 2004

13 De Schepper AM, "MR imaging of eosinophilic granuloma: report of 11 cases" 22 : 163-166, 1993

14 Resnick D, "Lipidoses, histiocytoses, and hypenlipoproteinemias. in: Diagnosis ofbone and joint disorders. Vol 4. 2nd ed" Saunders 2429-2439, 1988

15 Azouz EM, "Langerhans’cell histiocytosis: pathology, imaging and treatment of skeletal involvement" 35 (35): 103-15, 2005

16 Kilpatrick SE, "Langerhans’cell histiocytosis (histiocytosis X of bone)" 76 : 2471-2484, 1995

17 Leonidas JC, "Langerhans’ cell histiocytosis. In: Radiology: diagnosis, imaging, intervention. Vol 5" Lippincott 1-9, 1990

18 Favara BE, "Langerhans’ cell histiocytosis pathobiology and pathogenesis" 18 : 3-7, 1991

19 Howarth DM, "Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome" 85 : 2278-2290, 1999

20 Egeler RM, "Langerhans cell histiocytosis" 127 : 1-11, 1995

21 Broadbent V, "Histiocytosis syndromes in children. II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis" 17 : 492-495, 1989

22 Favara BE, "Histiocytosis X" 14 : 663-676, 1983

23 Stull MA, "From the archives of the AFIP: Langerhans cell histiocytosis of bone" 12 : 801-823, 1992

24 Dorfman HD, "Bone tumors" Mosby 690-701, 1997

25 Huvos AG, "Bone tumors" Saunders 695-771, 1991

26 Campanacci M, "Bone and soft tissue tumors, 2nd ed" Springer 857-876, 1999

27 Brown RE, "Angiotensin-converting enzyme, transforming growth factor β1, and interleukin 11 in the osteolytic lesions of Langerhans cell histiocytosis" 124 : 1287-1290, 2000

28 "A multicentre retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993: The French Langerhans’ Cell Histiocytosis Study Group" 75 : 17-24, 1996